MyJournals Home  

RSS FeedsB591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells (Oncogene)

 
 

11 january 2019 17:00:27

 
B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells (Oncogene)
 




 
75 viewsCategory: Oncology
 
CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells (Oncogene)
BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis (Oncogene)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten